← FDA Drug Approvals (Drugs@FDA)

TRETINOIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2025-02-27

Drug application

FDA Application #
ANDA218245
Application type
Abbreviated New Drug Application (Generic)
Brand name
TRETINOIN
Generic name
TRETINOIN
Active ingredients
TRETINOIN
Dosage form
GEL
Route
TOPICAL
Marketing status
Prescription
Sponsor
AUROBINDO PHARMA LTD
Manufacturer
Aurobindo Pharma Limited
First approval
2025-02-27

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown